Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.600
-0.050 (-1.37%)
Feb 5, 2026, 4:00 PM EST - Market closed
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $264 million as of February 6, 2026. Its market cap has increased by 2,137.30% in one year.
Market Cap
264.00M
Enterprise Value
250.11M
1-Year Change
2,137.30%
Ranking
Category
Stock Price
$3.60
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $264.00M, an increase of 366.43%. That is a compound annual growth rate of 16.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 264.00M | -25.47% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 269.13M |
| Coherus Oncology | 264.10M |
| Neurogene | 263.33M |
| Nautilus Biotechnology | 256.40M |
| Climb Bio | 251.14M |
| OmniAb | 246.16M |
| Heron Therapeutics | 245.71M |
| Enlivex Therapeutics | 243.32M |